A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2001
11/29/2001	WO2001089582A1 Preventives and remedies for pulmonary hypertension
11/29/2001	WO2001089574A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089541A1 Use of lactobacillus casei in immunostimulatory peptides
11/29/2001	WO2001089533A2 Preparation for stabilizing the protective layer on the epithelium of the cornea or the alveoli
11/29/2001	WO2001089527A2 Pharmaceutical composition comprising loratadine and a nasal decongestant
11/29/2001	WO2001089512A1 Drugs acting on the bronchi
11/29/2001	WO2001089504A1 Tropolone derivatives and pharmaceutical compositions
11/29/2001	WO2001089492A1 Novel composition
11/29/2001	WO2001089491A1 Novel process
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001060835A8 Purine derivatives
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	WO2000010548A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046970 Inhibition of selectin binding
11/29/2001	US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001	US20010046511 Water soluble film for oral administration with instant wettability
11/29/2001	US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001	US20010046495 Use of cross-linked, covalently bound urokinase plasminogen activator (scuPAR)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046474 Stabilized preparations for use in metered dose inhalers
11/29/2001	EP1143949A3 19-nor-vitamin d3 compounds with calcemic activity
11/29/2001	DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410401A1 A novel treatment for cough
11/29/2001	CA2410350A1 Use of lactobacillus casei in immunostimulatory compounds
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410004A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001	CA2409868A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408145A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2405459A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157749A2 Metered dose inhaler for albuterol
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157007A1 Pde iv inhibiting compounds, compositions and methods of treatment
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1156854A2 Use of ceramides for the treatment of cystic fibrosis
11/28/2001	EP1156790A1 Combinations of formoterol and mometasone furoate for asthma
11/28/2001	EP1054685B1 Liquid crystal forms of cyclosporin
11/28/2001	EP0918760B1 Biologically active benzothiazolone ethanamines
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1323623A Multipurpose medicine made of bamboo liquid and honey and its prepn.
11/28/2001	CN1323584A External-use medicine liquid for diseases of eye, ear, nose and throat
11/28/2001	CN1075376C Nose drops
11/28/2001	CN1075357C Dongxing cold tea
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323216 Selective antagonists of the 5-ht.sub.3 serotonin-like receptor and can therefore be used, as anti-emetics as well as in various pathological conditions of the central nervous system, and as antitussives.
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323187 Therapeutic dinucleotide and derivatives
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/22/2001	WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001	WO2001088126A2 REGULATION OF HUMAN α1Α ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087882A2 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087841A1 Novel polymorph v of torasemide
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087830A2 Substituted thioacetamides
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087350A2 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087332A1 Compositions and methods for treatment of mucosal infections
11/22/2001	WO2001087326A1 Use of an enterobacterium ompa protein as antimicrobial agent
11/22/2001	WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001	WO2001087234A2 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001	WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE

1 ... 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 ... 878